Diagnostic Testing During a Pandemic
A digital health company’s quest to improve the delivery and scaling of lab testing
Pouria Sanae, CEO of ixlayer, a technology company, explains the obstacles surrounding the distribution of remote lab tests pre-, during and post-pandemic, the shift to at-home Covid screenings, the logistical challenges in collaborating with different US regions, and the concept of the “pre-patient” model for preventative care.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Recent Videos
Related Content
